Gossamer Bio, Inc. — Director's Dealing 2022

Jul 15, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Gossamer Bio, Inc. (GOSS)
CIK: 0001728117
Period of Report: 2022-07-15

Reporting Person: Carter Laura (Chief Scientific Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-07-15	Common Stock	P	6934	$7.21	Acquired	87168	Direct

Footnotes

F1: The Reporting Person's purchase of common stock reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, to the extent of 6,934 shares, with the Reporting Person's sale of 6,934 shares of common stock at a price ranging from $8.278 to $8.25 per share on July 1, 2022 and March 16, 2022. The Reporting Person paid to the Issuer $7,351.42, representing the full amount of the profit realized in connection with the short-swing transaction.